The Assisted Reproductive Technology (ART) market size is expected to reach USD 39.12 Billion in 2030 and register a revenue CAGR of 7.4% during the forecast period, according to the latest report by Reports and Data. Increasing demand for surrogacy by the LGBTQIA+ community and increasing success rates of in-vitro fertilization (IVF) and related ART procedures are driving market revenue growth.
Infertility can be treated using ART. ART assists in treating infertility by providing a variety of procedures a patient can choose from according to the patient’s need and their medical history. The most popular and efficient type of ART is in-vitro fertilization (IVF). Donor eggs, donor sperm, or frozen embryos are some popular services availed by patients in ART. Surrogacy is a major driving factor for market growth as more people are moving past the social stigma associated with it and focusing on the benefits that it provides.
Multiple gestation or multiple pregnancies is a major restrain for the ART market as it is considered a great risk to the patient and the infant’s health. The Centers for Disease Control (CDC) reported that while ART accounts for 17% of twins born to couples, the risk of multiple pregnancies while undergoing ART procedures is 27 times more than those who conceive naturally. This factor is restraining market growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1402
Market Dynamics:
The pharma and healthcare sector has significantly advanced in the recent years and is expected to register steady revenue growth over the forecast period owing to rapid innovations in medical technology, increasing investments, rising healthcare expenditure and high adoption of advanced products and systems. Factors such as rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders across the globe, rising cases of coronavirus, improving healthcare infrastructure and research facilities, and increasing adoption of remote patient monitoring services and home care settings are expected to fuel global market revenue growth over the forecast period. In addition, increasing number of hospitals and ambulatory care centers worldwide, high demand for personalized medicine, increasing investments in drug discovery and growing investments by public and private sectors are expected to drive global market growth in the coming years.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product service portfolio. The Assisted Reproductive Technology (ART) market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in RD, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (US), Vitroife AB (Sweden), Thermo Fisher Scientific (US), Celmatix, Inc. (US), Anecova (Switzerland), OvaScience (US), Ferring Pharmaceuticals (US), , and FertiPro N.V. (Belgium).
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1402
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Assisted Reproductive Technology (ART) Market Segmentation:
Type Technology Outlook (Revenue, USD Billion; 2019–2030)
- Artificial Insemination
- Surrogacy
- Ovulation Induction
- Others
Procedure Outlook (Revenue, USD Billion; 2019–2030)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Embryo/Egg Banking
- Others
Procedure Technology Outlook (Revenue, USD Billion; 2019–2030)
- In-Vitro Fertilization
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without ICSI
- Artificial Insemination-Intrauterine Insemination
- Frozen Embryo Replacement
- Others
End-use Outlook (Revenue, USD Billion; 2019–2030)
- Fertility Clinics
- Hospitals
- Clinical Research
- Others
Regional Outlook:
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1402
Thank you for reading the report. Kindly note that we also offer customized reports according to the client requirement. Contact us to know more about the customization feature and our team will provide you with the best customized report.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
